Record Orders and Backlog
Orders hit a record $2.284 billion, up 28.2% YoY, with organic orders rising 25% and acquisitions contributing 6%. Backlog reached a record $4.11 billion, up 14.8% from year-end 2025.
AMETEK INC/ is expected to release its Q3 2026 10-Q filing on October 28, 2026, before market open. Last quarter: AMETEK posted record Q2 FY2026 results with 15% revenue growth and strong orders, while adjusted margins expanded and the company announced a $5.0 billion acquisition of Indicor Instrumentation.
EPS Estimate
$2.07
Revenue Estimate
$2.03B
Analyst consensus from Finnhub and Financial Modeling Prep. Actual results posted within minutes of the SEC filing on the AME page.
Drawn from management commentary in the Q2 2026 10-Q:
Orders hit a record $2.284 billion, up 28.2% YoY, with organic orders rising 25% and acquisitions contributing 6%. Backlog reached a record $4.11 billion, up 14.8% from year-end 2025.
On May 5, 2026, AMETEK agreed to acquire Indicor Instrumentation for ~$5.0 billion in cash. The target has annual sales of ~$1.1 billion and will be integrated into EIG or EMG. Closing is expected in H2 2026, subject to regulatory approvals.
Total sales growth of 15.0% included a 10% organic increase and a 5% lift from acquisitions. International sales rose 14.3%, led by strength in Europe and Asia.
Revenue
$2.04B
+14.98% YoY
EPS (Diluted)
$1.77
+14.19% YoY
Operating Income
$528.19M
+14.42% YoY
Add AME to your watchlist to get the AI analysis in your inbox within minutes of the 10-Q filing.